Adenovirus Vector
Oncolytic adenovirus replicates selectively in tumors
Published in Vaccine Weekly, January 4th, 2006
According to recent research from the United States, "We have constructed a novel oncolytic adenovirus (Ad) vector, named VRX-011, in which the replication of the vector is targeted to cancer cells by the replacement of the wild-type Ad E4 promoter with the human telomerase reverse transcriptase (hTERT) promoter."
"Genes in the Ad E4 transcription unit are essential for Ad replication; therefore, VRX-011 will grow efficiently only in cells in which the hTERT promoter is active, that is, in a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-01-04)
More Articles from Vaccine Weekly
- Cervical Cancer
Pharma company submits biologics license application for papillomavirus vaccine to U.S. FDA - Chickenpox Vaccine
Varicella vaccination in Australia is the focus of review - Escherichia Coli Vaccine
Live diarrheal vaccine imprints Th2 cell bias and is anti-inflammatory - SARS Vaccine
Inactivated virus immunization modulates immune response to SARS spike glycoprotein - Allergy & Immunology
Mycobacteria exposure primes immune system for evolutionarily diverse heat shock proteins - Antigen Receptors
Norovirus capsid protein forms particle that binds to histo-blood group antigen receptors - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
